Mark Painter, PhD
Mark graduated from The University of St. Thomas in St. Paul, Minnesota, in 2014 with a B.S. in Biology, and subsequently entered the Graduate Program in Immunology at the University of Michigan. During graduate school, he studied how HIV evades the immune response and establishes a persistent infection, discovering a new class of drug that could help the immune system recognize and kill HIV-infected cells. Mark completed his PhD in Immunology in November 2020 and began a postdoctoral research fellowship at the University of Pennsylvania in January 2021. His postdoctoral research focuses on human immunology, and he currently co-leads a team that has published several high-profile studies on the immune response to SARS-CoV-2 vaccination and infection, appearing in journals including Science Immunology, Immunity, Nature Medicine, and Science.